A Study on the Substance Balance of [14C]XY0206 in Healthy Adult Chinese Men

Clinical trial NCT06823232 · COMPLETED

Trial details

NCT number: NCT06823232
Sponsor: Shijiazhuang Yiling Pharmaceutical Co. Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metabolism of Radioactive Substances

Start date: 2024-11-06
Primary completion: 2024-12-05
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.